Effectiveness and safety of a new helmet CPAP configuration allowing tidal volume monitoring in patients with COVID-19.
COVID-19
CPAP
Helmet
Tidal volume
Journal
Pulmonology
ISSN: 2531-0437
Titre abrégé: Pulmonology
Pays: Spain
ID NLM: 101723786
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
30
03
2021
revised:
28
06
2021
accepted:
30
06
2021
pubmed:
31
7
2021
medline:
31
7
2021
entrez:
30
7
2021
Statut:
ppublish
Résumé
High generated tidal volumes (V This prospective observational study was performed in the respiratory intermediate care unit of University Hospital in Turin, Italy, between March 24th, and June 15th, 2020. Included patients were treated with CPAP via a single-limb intentional leak configuration by a turbine-driven ventilator, provided with a dedicated patch. Effectiveness and safety of the configuration and healthcare workers safety were the outcomes of the study. Thirty-five patients were included in this study. Median age was 67 years (IQR 57-76 years), and 30 patients (85.7%) were men. Median value of overall leaks (intentional plus unintentional) was 68 L/min (IQR 63-75). Reliability of V The use of h-CPAP for treating COVID-19 in this configuration allowed for reliable V
Sections du résumé
BACKGROUND
BACKGROUND
High generated tidal volumes (V
METHODS
METHODS
This prospective observational study was performed in the respiratory intermediate care unit of University Hospital in Turin, Italy, between March 24th, and June 15th, 2020. Included patients were treated with CPAP via a single-limb intentional leak configuration by a turbine-driven ventilator, provided with a dedicated patch. Effectiveness and safety of the configuration and healthcare workers safety were the outcomes of the study.
MAIN FINDINGS
RESULTS
Thirty-five patients were included in this study. Median age was 67 years (IQR 57-76 years), and 30 patients (85.7%) were men. Median value of overall leaks (intentional plus unintentional) was 68 L/min (IQR 63-75). Reliability of V
CONCLUSIONS
CONCLUSIONS
The use of h-CPAP for treating COVID-19 in this configuration allowed for reliable V
Identifiants
pubmed: 34326019
pii: S2531-0437(21)00135-5
doi: 10.1016/j.pulmoe.2021.06.012
pmc: PMC8266523
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S9-S17Informations de copyright
Copyright © 2021 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest GM, AC and CG declare a patent pending, in association with the University of Palermo - Italy (No. 102019000020532 – Italian Ministry of Economic Development) related to the content of this manuscript. CG received fees for lectures by Philips, and received payments by Philips for consultancies in the developing process of the EVO Ventilator and fees for lectures or consultancies from Resmed, Vivisol and Air Liquide not related to the present work.